Abstract:Objectives: Hypoxia is associated with human non-small cell lung cancers (NSCLC), which are highly resistant to chemotherapy. The hypoxia inducible factor (HIF) as a transcription factor in response to hypoxia indicates that it could be a novel, tumor-specific target for anticancer therapy. We hypothesized that disruption of HIF pathway through lentiviral vector-mediated HIF-1 alpha RNA interference (RNAi) could reverse the hypoxia-induced resistance to chemotherapy. Methods: We transfected Human NSCLC cell lines, SPCA1 and A549 with HIF-1 alpha specific RNAi lentiviral vectors as well as controls. HIF-1 alpha silenced cells [SPCA1/HIF-1 alpha(-) and A549/HIF-1 alpha(-)] were screened by blasticidin. They were incubated in 19 or 0.5% O-2 for 16 h followed by the assessment of chemosensitivity to cisplatin and doxorubicin with MTT and clonogenic assays. Quantitative RT-PCR and Western blot analysis were used to detect the expressions of HIF-1 alpha mRNA and protein, respectively. Moreover, flow cytometry was used to monitor the expression of P-glycoprotein. Results: Exposure of SPCA1 and A549 cells to 0.5% O-2 significantly increased resistance to cisplatin and doxorubicin, in contrast to cells incubated in normoxia. Transduction of SPCA1 with HIF-1 alpha RNAi vector resulted in sequence specific silencing with 87.2 and 84.6% decreases of HIF-1 alpha mRNA transcription and 97.3 and 94.8% of protein expressions in normoxia and hypoxia, respectively. Correspondingly, they are 89.2, 89.9% and 97.2, 88.4% decreases in A549 cells. Hypoxia-induced resistance to cisplatin and doxorubicin were reversed in SPCA1/HIF-1 alpha(-) and A549/HIF-1 alpha(-) cells. There was no significant P-glycoprotein increase induced by hypoxia in NSCLC cells. Conclusions: Our studies demonstrated that hypoxia-induced chemoresistance to cisplatin and doxorubicin in NSCLC cells is through the HIF pathway. MDR1 regulation may not be involved in hypoxia-induced chemoresistance. Combining delivery of HIF-1 alpha RNAi lentiviral vector with cisplatin-related chemotherapy regimens may enable us to develop more effective strategy for NSCLC therapy.

Silencing of HIF-1α Enhances the Radiation Sensitivity of Human Glioma Growth in Vitro and in Vivo.

Silencing of Heat Shock Protein 27 Increases the Radiosensitivity of Non‑small Cell Lung Carcinoma Cells.

GLUT-1 Sirna Enhances Radiosensitization of Laryngeal Cancer Stem Cells Via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis in Vitro and in Vivo.

Effect of Hypoxia-inducible Factor-1α Silencing on the Sensitivity of Human Brain Glioma Cells to Doxorubicin and Etoposide

Suppressing the Malignant Phenotypes of Glioma Cells by Lentiviral Delivery of Small Hairpin RNA Targeting Hypoxia-Inducible Factor-1Α.

Hypoxia-Inducible Factor-1 Alpha Downregulation By Small Interfering Rna Inhibits Proliferation, Induces Apoptosis, And Enhances Radiosensitivity In Chemical Hypoxic Human Hepatoma Smmc-7721 Cells

Suppressing The Malignant Phenotypes Of Glioma Cells By Lentiviral Delivery Of Small Hairpin Rna Targeting Hypoxia-Inducible Factor-1 Alpha

Upregulated AHIF-mediated Radioresistance in Glioblastoma.

Insulin‑like Growth Factor‑1 Receptor Knockdown Enhances Radiosensitivity Via the HIF‑1α Pathway and Attenuates ATM/H2AX/53BP1 DNA Repair Activation in Human Lung Squamous Carcinoma Cells

Anti-tumor Effect of Silencing Hif-1α and Survivin Genes Combined with X-ray Irradiation on Hypoxic Tumor Cells in Vitro

Anti-tumor Effect of Silencing HIF-lα and Survivin Genes Combined with Radiotherapy on Human Hepatoma Xenograft in Nude Mice

Effect of HIF-1α Siliencing on Human Lung Cancer Xenografts Radiosensitivity in Nude Mice

Silencing of FOXG1 confers radio-sensitivity through regulating autophagy in glioma cells

Hypoxia-Induced Resistance To Cisplatin And Doxorubicin In Non-Small Cell Lung Cancer Is Inhibited By Silencing Of Hif-1 Alpha Gene

Irradiation Enhances Expression of Cxcr4 in Murine Glioma Cells Via HIF-1α-independent Pathway

Silencing Lncrna GIHCG Increases Radiosensitivity of Glioma Cells by Up-Regulating Mir-146A-3p

Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene

Interference of HIF-1α by RNA to enhance radio sensitivity of HeLa cell tumor transplanted in BALB/c mice

Suppression of FoxO3a Increases Responsiveness of Glioma Cells to Radiation Treatment

Silencing of ataxia-telangiectasia mutated by siRNA enhances the in vitro and in vivo radiosensitivity of glioma.

Regulation of the radiosensitivity of tumor cells through HIF-1 alpha dependent intracellular redox status after fractionated radiation